HIM2442 – Pharmacology and Lab is a 1-credit course at Daytona State College introducing the most common drugs and laboratory tests used in medicine. It is written for coders, billers, and health information staff rather than for clinicians, and it is offered in the summer term.
The scope is deliberately practical and covers two things students often expect to be separate. Medications and laboratory results both appear constantly in the records this workforce handles, and both carry coding and billing consequences: a drug or an abnormal lab value frequently implies a diagnosis that must be documented before it can be coded, drug administration and laboratory tests are themselves billable services, and injectable and infused drugs are reported with specific codes and units.
Because it is a 1-credit course, it is a working orientation rather than a comprehensive pharmacology sequence — the goal is enough fluency to read a record with understanding, know when to look something up, and recognize when documentation warrants a query.
Content covers pharmacology fundamentals — terminology, and generic, brand, and chemical names; drug classification by body system and therapeutic use; routes of administration and their coding significance; major drug classes — cardiovascular, respiratory, endocrine including insulin, anti-infectives, analgesics including opioids, psychotropics, and anticoagulants; controlled substance schedules; common laboratory tests — the complete blood count, basic and comprehensive metabolic panels, lipid panel, liver and renal function, coagulation studies, HbA1c, urinalysis, and cultures; reading laboratory values — reference ranges, and what an abnormal result suggests; the drug-and-lab-to-diagnosis link — what a medication or result implies, and when to query; HCPCS Level II J-codes — reporting injectable and infused drugs; units and dosage for billing; laboratory and pathology coding basics; adverse effects, poisoning, and underdosing — the ICD-10-CM distinctions; drug references — efficient lookup; and compliance in drug and laboratory billing.
Florida's large hospital, oncology, and outpatient infusion sector makes this content directly employable, and infusion and oncology coding is one of the better-paid coding niches precisely because the drug rules are intricate and errors are expensive. A coder who is genuinely comfortable with J-codes, units, and infusion hierarchy is more valuable than one who avoids those charts.
Florida institutions do not agree on what this number contains, so this guide is written to Daytona State College's catalog and notes where others differ. The HIM prefix runs in at least two parallel numbering families with different titles, scopes, and credit values — Valencia College, for instance, uses HIM1012, HIM1110, HIM2222C and HIM2729C (4 credits each), with professional practice as L-suffixed HIM1800L/2810L/2820L. Those are different courses, not different versions of this one, and their credit values say nothing about this number.
Compare HIM programs by their whole sequence and total credits rather than course by course, and confirm the specific numbers your program requires. For certification eligibility what matters most is that your program is CAHIIM-accredited.
Worth emphasizing, because the course title says pharmacology and the DSC scope explicitly includes laboratory tests. The logic is identical to the drug side: a result frequently points to a condition that may not be documented.
The tests worth knowing by name and purpose are a short list: the complete blood count (infection, anemia, clotting), the basic and comprehensive metabolic panels (electrolytes, kidney and liver function, glucose), HbA1c (glycemic control over months, and a common diabetes indicator), lipid panel, coagulation studies such as INR (which pairs with anticoagulant therapy), urinalysis, and cultures with sensitivities (which pair with anti-infectives).
Two practical points. Learning drug and lab together is more efficient than separately, because they corroborate each other — warfarin plus INR monitoring, insulin plus HbA1c, an antibiotic plus a positive culture each tell a consistent story. And the same rule applies as for medications: an abnormal result is a reason to query, never a basis to code a diagnosis the provider has not documented.
The most consequential technical content in the course. HCPCS J-codes are billed in units defined by the code descriptor, and the unit is frequently not the amount administered. A code may be defined as "per 10 mg" while the record documents 40 mg — four units — and a code for a different drug may be per 1 mg or per vial.
Getting this wrong is not a rounding error. Billing 40 units where 4 are correct is a tenfold overcharge and, repeated, becomes a serious audit finding and potential false claim. Under-billing loses legitimate revenue silently.
The professional habits: read the code descriptor every time rather than relying on memory, because descriptors change with annual updates; convert documented dosage to units deliberately rather than assuming; and understand wastage rules — when a single-use vial is partially administered, the discarded amount may be reportable, but only with proper documentation and modifier use. These are precisely the items auditors sample.
A distinction ICD-10-CM draws sharply and coders routinely blur. The category depends on how the drug came to cause the problem:
The sequencing differs, the codes differ, and the clinical and legal implications differ. It is a favorite examination topic for exactly that reason, and in practice it requires reading the documentation carefully rather than pattern-matching on the drug name.
The study method that makes this course tractable. There are tens of thousands of drug products and new ones constantly; memorizing individual names is futile and unnecessary.
What works is learning classes and their suffixes, because generic naming is largely systematic: -pril is an ACE inhibitor (cardiovascular, so think hypertension or heart failure); -olol a beta blocker; -statin a lipid-lowering agent; -prazole a proton pump inhibitor; -cillin a penicillin antibiotic; -mab a monoclonal antibody. Once you know the class, you know the likely indication, which is the actual coding task.
Build a chart of your own: class, suffix, common examples, what it treats, and the diagnosis it implies. That last column is the one that matters for coding, and building it yourself is what makes it stick. For anything unfamiliar, a free reference resolves it in seconds — the professional skill is knowing how to look it up efficiently, not having memorized it.
The point where this course meets the ethical core of coding. Medications are strong clinical clues: a patient on insulin very probably has diabetes; on warfarin, probably a clotting disorder or atrial fibrillation; on levothyroxine, probably hypothyroidism.
That inference is exactly what makes this course valuable — and it is not permission to code the diagnosis. A coder may not assign a diagnosis code because a medication implies it. What the inference licenses is a query: a compliant, non-leading request asking the provider to document the clinical significance of the medication.
Done well, this is one of the highest-value things a coder does — it captures conditions that genuinely affect severity and payment and that would otherwise be lost, and it improves the accuracy of the record. Done badly — by leading the provider toward a diagnosis, or by simply assuming — it is non-compliant and, at scale, fraudulent. The distinction is the whole professional skill.
The ethical and legal core of the profession, and it does not soften at the advanced level. A code must be supported by the provider's documentation. A coder may not infer a diagnosis from lab values, medications, or clinical likelihood, however obvious it seems.
The correct instrument is the query: a written request to the provider for clarification. A compliant query is non-leading — it presents the clinical indicators and asks the provider to interpret them rather than suggesting the answer.
The stakes are real and rise with seniority. Upcoding — reporting a more severe or better-reimbursed code than documentation supports — is health care fraud under the False Claims Act, and coders have been personally implicated. So has coding under employer pressure. A coder's professional obligation runs to the accuracy of the record, and "I was told to" is not a defense. If you are pressured, document it and escalate through compliance.
Worth checking before assuming a course maps across institutions. Health information management is numbered inconsistently in Florida, and the differences are not cosmetic:
Credit values differ across the families as well — coding courses run 3 credits in one and 4 in the other. Practical consequence: compare HIM programs by their whole sequence and total credits, not course by course, and confirm the specific numbers your program requires. For certification eligibility what matters most is that your program is CAHIIM-accredited — verify that before enrolling if RHIT is your goal.
Worth stating precisely, because the numbering is often misread. In Florida's Statewide Course Numbering System the first digit denotes the year in which the course is normally offered — 1 for the first year, 2 for the second, and so on — not how well it transfers. 1000- and 2000-level courses transfer transparently between Florida public institutions, and 3000 to 4000 transfers without difficulty since both are upper division. The boundary that matters is lower division to upper division: taking a 2000-level course toward a 3000-level requirement is the problematic step. PSAV (0-level) courses do not transfer as college credit at all; that pathway runs through articulation agreements instead.
Separately, SCNS equivalency is keyed to the course number. A program requiring a specific number is satisfied by that number from any participating institution; a different number with similar content still transfers as credit, but the receiving program decides whether it fills that requirement or counts as elective. That is a curriculum question for an advisor, not a barrier to the credit transferring.
Generated September 2, 2026 · Updated September 2, 2026